Skip to main content
logo
Latigo Biotherapeutics, Inc. (LTGO)
NASDAQ: LTGO · Real-Time Price · USD
12.60
-0.41 (-3.15%)
At close: Nov 6, 2026, 4:00 PM EST
12.57
-0.03 (-0.22%)
After-hours: Nov 6, 2026, 6:57 PM EST

Latigo Biotherapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Sep '26 Dec '25 Dec '24
Net Income
--109.17-61.18
Depreciation & Amortization
-0.250.24
Stock-Based Compensation
-6.732.77
Other Operating Activities
-2.120.33
Change in Accounts Payable
--1.965.75
Change in Other Net Operating Assets
-4.481.14
Operating Cash Flow
--97.56-50.96
Operating Cash Flow Growth
---

Investing Activities

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Sep '26 Dec '25 Dec '24
Capital Expenditures
--0.14-0.07
Investing Cash Flow
--0.14-0.07

Financing Activities

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Sep '26 Dec '25 Dec '24
Issuance of Common Stock
-0.120.61
Financing Cash Flow
-149.50.61

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Sep '26 Dec '25 Dec '24
Net Cash Flow
-51.8-50.42

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Sep '26 Dec '25 Dec '24
Free Cash Flow
--97.69-51.03
Free Cash Flow Growth
---
Free Cash Flow Per Share
--115.65-75.14
Levered Free Cash Flow
--59.47-
Unlevered Free Cash Flow
--59.47-

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Sep '26 Dec '25 Dec '24
Change in Working Capital
-2.526.89
SEC Filings: 10-K · 10-Q